Bronchopulmonary dysplasia and oxidative stress: Are we closer to an understanding of the pathogenesis of BPD?

Acta Paediatrica, International Journal of Paediatrics

Volumn 86, Issue 12, 1997, Pages 1277-1282

  Saugstad, O D ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Bronchopulmonary dysplasia; Inflammation; Oxygen radicals; Peroxidation products; Pulmonary surfactant

Indexed keywords

LUNG SURFACTANT; OXYGEN RADICAL;

HUMAN; LUNG DYSPLASIA; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

EID: 0031446802     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1997.tb14897.x     Document Type: Review

References (67)

1. Kari MA, Hallman M, Eronen M, Teramo K, Virtanen M, Koivisto M, Ikonen RS. Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant: a randomized placebo-controlled multicenter study. Pediatrics 1994; 93: 730-6
2. Northway WH, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 1967; 276: 357-68
3. O'Brodovich HM, Mellins RB. Bronchopulmonary dysplasia. Unresolved neonatal acute lung injury. Am Rev Respir Dis 1985; 132: 694-709
4. Saugstad OD. Oxygen toxicity in the neonatal period. Acta Paediatr Scand 1990; 79: 881-92
5. Philips AGS. Oxygen plus pressure plus time: the etiology of bronchopulmonary dysplasia. Pediatrics 1975; 55: 44-50
6. Saugstad OD, Gluck L. Plasma hypoxanthine levels in newborn infants: a specific indicator of hypoxia. J Perinat Med 1982; 10: 266-72
7. Saugstad OD, Hallman M, Abraham J, Cochrane CG, Espstein B, Gluck L. Hypoxanthine and oxygen induced lung injury: a basic mechanism of tissue damage? Pediatr Res 1984; 18: 501-4
8. Saugstad OD. Hypoxanthine as an indicator of hypoxia: its role in health and disease through free radical production. Pediatr Res 1988; 23: 143-50
9. Saugstad OD. Oxygen radicals and pulmonary damage. Pediatr Pulmonol 1985; 1: 167-75
10. Saugstad OD. Role of xanthine oxidase and its inhibitor in hypoxia: reoxygenation injury. Pediatrics 1996; 98: 103-7
11. Babior BM, Kipnes RS, Curnutte JT. Biological defense mechanisms. The production by leukocytes of superoxide - a potential bactericidal agent. J Clin Invest 1973; 52: 741-4
12. 2-rich environment: the antioxidant enzymes in the developing rabbit lung. Pediatr Res 1984; 18: 240-4
13. Yam J, Frank L, Roberts RJ. Age-related development of pulmonary antioxidant enzymes in the rat. Proc Soc Exp Biol Med 1978; 157: 293-6
14. Frank L, Sosenko IR. Prenatal development of lung antioxidant enzymes in four species. J Pediatr 1987; 110: 106-10
15. Tanswell AK, Freeman BA. Pulmonary antioxidant enzyme maturation in the fetal and neonatal rat. 1. Developmental profiles. Pediatr Res 18; 584-7
16. Gerdin E, Tyden O, Erikson UJ. The development of antioxidant enzymatic defense in the perinatal rat lung. Activities of superoxide dismutase, gluthathione peroxidase and catalyse. Pediatr Res 1984; 19: 687-91
17. Hayashibe H, Asayama K, Dobashi K, Kato K. Prenatal development of antioxidant enzymes in the rat lung, kidney, and heart: marked increase in immunoreactivity superoxide dismutase, glutathione peroxidase, and catalase in the kidney. Pediatr Res 1990; 27: 472-5
18. Frank L, Sosenko IRS. Failure of premature rabbits to increase antioxidant enzymes during hyperoxic exposure: increased susceptibility to pulmonary oxygen toxicity compared with term rabbits. Pediatr Res 1991; 29: 292-6
19. Chen Y, Whitney PL, Frank L. Comparative responses of premature versus full-term newborn rats to prolonged hyperoxia. Pediatr Res 1994; 35: 233-7
20. Autor AP, Frank L, Roberts RJ. Developmental characteristics of pulmonary superoxide dismutase: relationship to idiopathic respiratory distress syndrome. Pediatr Res 1976; 10: 154-8
21. Phylactos AC, Leaf AA, Costeloe K, Crawford MA. Erythrocyte copper/zinc superoxide dismutase exhibits reduced activity in preterm and low birthweight infants at birth. Acta Paediatr 1995; 84: 1421-5
22. Pallardo FV, Sastre J, Asensi M, Rodrigo F, Estrela JM, Vina J. Physiological changes in glutathione metabolism in foetal and newborn rat liver. Biochem J 1991; 274: 891-3
23. Vina J, Vento M, Garcia-Sala F, Puertes IR, Gasco E, Sastre J, et al. L-Cysteine and glutathione metabolism are impaired in premature infants due to cystathionase deficiency. Am J Clin Nutr 1995; 61: 1067-9
24. Sullivan JL, Newton RB. Serum antioxidant activity in neonates. Arch Dis Child 1988; 63: 748-57
25. Lindeman JHN, van Zoeren-Grobben D, Shrijver J, Speek AJ, Poorthuis BJHM, Berger HM. The total free radical ability of cord blood plasma in preterm and term babies. Pediatr Res 1989; 26: 20-4
26. Saugstad OD. Mechanisms of tissue injury by oxygen radicals: implications for neonatal disease. Acta Paediatr 1996; 85: 1-4
27. Johnson KJ, Fantone JC, Kaplan J, Ward PA. In vivo damage of rat lungs by oxygen metabolites. J Clin Invest 1981; 67: 983-93
28. Saugstad OD, Hallman M, Becher G, Oddoy A, Lachmann B. Respiratory failure caused by intratracheal saline: additive effect of xanthine oxidase. Biol Neonat 1988; 54: 61-7
29. Saugstad OD, Becher G, Grossmann M, Oddoy A, Merker G, Lachmann B. Acute and chronic lung damage in guinea pigs induced by xanthine oxidase. Intensive Care Med 1987; 13: 30-2
30. Russell GAB, Cooke RWI. Randomised controlled trial of allopurinol prophylaxis in very preterm infants. Arch Dis Child 1995; 73: F27-F31
31. Wilborn A, Evers LB, Canada AT. Oxygen toxicity to the developing lung of the mouse: role of reactive oxygen species. Pediatr Res 1996; 40: 225-32
32. Han RN, Buch S, Tseu I, Young J, Christie NA, Frndova H, et al. Changes in structure, mechanics, and insulin-like growth factor-related gene expression in the lungs of newborn rats exposed to air or 60% oxygen. Pediatr Res 1996; 39: 921-9
33. Kelly FJ, Lubec G. Hyperoxic injury of immature guinea pig lung is mediated via hydroxyl radicals. Pediatr Res 1995; 38: 286-91
34. Clerch LB, Wright AE, Coalson JJ. Lung manganese superoxide dismutase protein expression increases in the baboon model of bronchopulmonary dysplasia and is regulated at a posttranscriptional level. Pediatr Res 1996; 39: 253-8
35. Pitkanen OM, Hallman M, Andersson SM. Correlation of free oxygen radical-induced lipid peroxidation with outcome in very low birthweight infants. J Pediatr 1990; 116: 760-4
36. Varsila E, Pitkanen O, Hallman M, Andersson S. Immaturity-dependent free radical activity in premature infants. Pediatr Res 1994; 36: 55-9
37. Varsila E, Hallman M, Andersson S. Free-radical-induced lipid peroxidation during the early neonatal period. Acta Paediatr 1994; 83: 692-5
38. Gladstone IM, Levine RL. Oxidation of proteins in neonatal lungs. Pediatrics 1994; 93: 764-8
39. Varsila E, Pesonen E, Andersson S. Early protein oxidation in the neonatal lung is related to development of chronic lung disease. Acta Paediatr 1995; 84: 1296-9
40. Ogihara T, Okamoto R, Kim H-S, Nagai A, Morinobu T, Moji H, et al. New evidence for the involvement of oxygen radicals in triggering neonatal chronic lung disease. Pediatr Res 1996; 39: 117-9
41. 2 and lipid peroxidation in the lungs of premature infants. Pediatr Res 1996; 39: 329A
42. Lubec G, Widness JA, Hayde M, Menzel D, Pollack A. Hydroxyl radical generation in oxygen treated infants. Pediatrics 1997; 100: 200-4
43. van Zoeren-Grobben D, Lindeman JHN, Houdkamp E, Moison RMW, Wijnen JT, Berger HM. Markers of oxidative stress and antioxidant activity in plasma and erythrocytes in neonatal respiratory distress syndrome. Acta Paediatr 1997; 86: 1356-62
44. Moison RMW, Haasnoot AA, van Zoeren-Grobben D, Berger HM. Red blood cell glutathione and plasma sulfhydryls in chronic lung disease of the newborn. Acta Paediatr 1997; 86: 1363-9
45. Merritt TA, Cochrane CG, Holcomb K, Bohl B, Hallman M, Strayer D, et al. Elastase and alpha 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia. J Clin Invest 1983; 72: 656-6
46. Groneck P, Speer CP. Inflammatory mediators and bronchopulmonary dysplasia. Arch Dis Childhood 1995; 73: F1-F3
47. Ogden B, Murphy SA, Saunders G, Pathak D, Johnson D. Neonatal lung neutrophils and elastase/proteinase inhibitor imbalance. Am Rev Respir Dis 1984; 130: 817-21
48. Groneck P, Gotze-Speer B, Oppermann M, Eiffert H, Speer CP. Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates. Pediatrics 1994; 93: 712-8
49. Kojima T, Sasai M, Kobayashi Y. Increased soluble ICAM-1 in tracheal aspirates of infants with bronchopulmonary dysplasia. Lancet 1993; 342: 1023-4
50. Etzioni A. Adhesion molecules - their role in health and disease. Pediatr Res 1996; 39: 191-8
51. Fellman V, Raivio KO. Reperfusion injury as a mechanism of brain damage after perinatal asphyxia. Pediatr Res 1997; 41: 599-606
52. Stefano JL, Spear ML, Pearlman SA, Fawcett P, Proujanski R. Soluble Interleukin-2-receptor levels in infants with bronchopulmonary dysplasia. Pediatr Pulmonol 1992; 14: 58-62
53. Holm BA, Matalon S, Finkelstein JN, Notter RH. Type II pneumocyte changes during hyperoxic lung injury and recovery. J Appl Physiol 1988; 65: 2672-8
54. Nogee LM, Wispe JR, Clark JC, Weaver T, Whitsett JA. Increased expression of pulmonary surfactant proteins in oxygen exposed rats. Am J Respir Cell Mol Biol 1991; 4: 102-7
55. 2-mediated injury of type II cell surfactant metabolism and protection with PEG-catalase. Am J Physiol 1991; 261: C751-C757
56. Novotny WE, Hudak BB, Matalon S, Holm BA. Hyperoxic lung injury reduces exogenous surfactant clearance in vivo. Am J Respir Crit Care Med 1995; 151: 1843-7
57. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87: 1620-4
58. Haddad IY, Ischiropoulos H, Holm BA, Beckman JS, Baker JR, Matalon S. Mechanisms of peroxynitrite-induced injury to lung surfactants. Am J Physiol 1993; 265: L555-L564
59. Dhar V, Hallman M, Lappalainen U, Bry K. Interleukin-1-alpha upregulates the expression of surfactant protein-A in rabbit lung explants. Biol Neonate 1997; 71: 46-52
60. Nilsson R, Grossmann G, Berggren P, Robertson B. Surfactant treatment in experimental hyaline membrane disease. Eur J Respir Dis 1981; 62: 441-9
61. Robertson B, Berry D, Curstedt T, Grossmann G, Ikegami M, Jacobs H, et al. Leakage of protein in the immature rabbit lung; effect of surfactant replacement. Respir Physiol 1985; 61: 265-76
62. Chen Y, Sosenko IL, Frank L. Positive regulation of pulmonary antioxidant enzyme gene expression by prenatal thyrotropin releasing hormone plus dexamethasone treatment in premature rats exposed to hyperoxia. Pediatr Res 1995; 37: 611-6
63. Rosenfeld W, Evans H, Conception L, Jhaveri R, Schaeffer H, Friedman A. Prevention of bronchopulmonary dysplasia by administration of bovine superoxide dismutase in preterm infants with respiratory distress syndrome. J Pediatr 1984; 105: 781-5
64. Davis JM, Rosenfeld WN, Sanders RJ, Gonenne A. Prophylactic effects of recombinant human superoxide dismutase in neonatal lung injury. J Appl Physiol 1993; 74: 2234-41
65. Davis JM, Rosenfeld WN, Richter SE, Parad RP, Gewolb IH, Spitzer AR, et al. Safety and pharmacokinetics of multiple doses of recombinant human CuZn superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome. Pediatrics 1997; 100: 24-30
66. Shenai JP, Kennedy KA, Stahlman MT. Clinical trial of vitamin A supplementation in infants susceptible to bronchopulmonary dysplasia. J Pediatr 1987; 111: 269-77
67. Watts JL, Milner R, Zipursky A, Paes B, Ling E, Gill G, et al. Failure of supplementation with vitamin E to prevent bronchopulmonary dysplasia in infants less than 1500g birthweight. Eur Respir J 1991; 4: 188-90